{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-033285","form_type":"8-K","ticker":"ALBT","cik":"0001630212","company_name":"Avalon GloboCare Corp.","filed_at":"2023-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.738988+00:00","generated_at":"2026-06-16T09:02:37.617149+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Avalon GloboCare reports LSM 2022 revenue $14.7M, net income $6.3M; 40% interest acquired Feb 2023","bullets":["LSM FY2022: revenue $14.7M, gross profit $8.1M, net income $6.3M, total operating expense $2.4M.","Avalon acquired 40% of LSM in Feb 2023; profit-sharing arrangement expected to produce significant future cash flow.","LSM provides broad diagnostic tests (drug testing, toxicology, pharmacogenetics, etc.) and has completed 600K+ tests since inception.","CEO cites fragmented lab market as roll-up opportunity to leverage LSM infrastructure for synergies."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-033285","json":"https://secwatch.observer/filing/0001213900-23-033285.json","markdown":"https://secwatch.observer/filing/0001213900-23-033285.md","text":"https://secwatch.observer/filing/0001213900-23-033285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023033285/0001213900-23-033285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023033285/ea177537-8k_avalon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T09:02:37.617149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dce577c24be89658d38b311d2b876b8c92899a8b","claim":"Avalon GloboCare Corp. reported the twelve months ended December 31, 2022 results: revenue $14.7 million, net income $6.3 million.","evidence_excerpt":"LSM 2022 Financial Highlights · Revenue was $14.7 million · Gross profit was $8.1 million · Total operating expense was $2.4 million · Net income was $6.3 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000121390023033285/0001213900-23-033285-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the twelve months ended December 31, 2022"},{"label":"Revenue","value":"$14.7 million"},{"label":"Net income","value":"$6.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}